Breaking News, Collaborations & Alliances

WuXi PharmaTech, Pfizer Sign ADME Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech has signed a new three-year, in vitro ADME collaboration agreement with Pfizer. The companies will establish ADME assays to provide in vitro screening services on compounds WuXi PharmaTech synthesizes for Pfizer. The evaluation of ADME properties is a key step in the drug discovery and development process. WuXi’s goal is to provide key information for the improvement of pharmacokinetic properties of Pfizer’s compounds.     The two companies have been involved in va...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters